Header cover image

Pharmaceuticals & Biotech Top Rated Asian Stocks

Results

19

0 new

Financially healthy companies listed on Asian stock exchanges with an impressive track record.

19 companies

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

500420

₹3,321.80

7D

2.4%

1Y

25.8%

Xiamen Amoytop Biotech

Market Cap: CN¥30.8b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥75.60

7D

-4.3%

1Y

24.9%

Ipca Laboratories

Market Cap: ₹353.3b

A pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia.

IPCALAB

₹1,392.40

7D

-3.5%

1Y

3.9%

Ajanta Pharma

Market Cap: ₹345.4b

A specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages.

AJANTPHARM

₹2,765.80

7D

3.1%

1Y

24.8%

Gan & Lee Pharmaceuticals

Market Cap: CN¥28.9b

A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.

603087

CN¥48.48

7D

7.8%

1Y

-3.1%

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥16.1b

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.

000403

CN¥22.04

7D

-2.2%

1Y

-24.8%

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥11.9b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

688076

CN¥53.01

7D

2.2%

1Y

-5.4%

Blue Jet Healthcare

Market Cap: ₹118.9b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

BLUEJET

₹685.40

7D

-8.7%

1Y

76.7%

Xiamen Kingdomway Group

Market Cap: CN¥9.7b

Engages in the manufacturing and sale of the nutrition and health products in China and internationally.

002626

CN¥15.98

7D

0.4%

1Y

2.8%

Granules India

Market Cap: ₹110.4b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.

532482

₹455.50

7D

-5.2%

1Y

7.7%

Aurisco PharmaceuticalLtd

Market Cap: CN¥8.5b

Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide.

605116

CN¥20.96

7D

-3.1%

1Y

-14.1%

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥8.0b

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

CN¥14.96

7D

2.3%

1Y

31.1%

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.0b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

300705

CN¥16.08

7D

-6.4%

1Y

-39.7%

Ami Organics

Market Cap: ₹89.3b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

AMIORG

₹1,090.30

7D

-0.5%

1Y

77.2%

Consun Pharmaceutical Group

Market Cap: HK$7.9b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$9.50

7D

-1.9%

1Y

62.4%

Akums Drugs and Pharmaceuticals

Market Cap: ₹82.5b

Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.

AKUMS

₹524.45

7D

3.7%

1Y

n/a

Innova Captab

Market Cap: ₹50.8b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

INNOVACAP

₹888.20

7D

-1.8%

1Y

87.7%

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.1b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.

688687

CN¥24.57

7D

-9.1%

1Y

-17.9%

Essex Bio-Technology

Market Cap: HK$2.6b

An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.

1061

HK$4.54

7D

11.3%

1Y

97.4%